Second quarter 2018
Highlights
Second quarter 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
We look forward to entering a new growth phase led by our increasing focus on Speciality Care and our leadership positions in Emerging Markets and Vaccines
Olivier Brandicourt
Chief Executive Officer